Population-Based Risk Assessment of APOL1 on Renal Disease-Reference-Cited by-同舟云学术

Population-Based Risk Assessment of APOL1 on Renal Disease

Published:2011-10-13 Issue:11 Volume:22 Page:2098-2105
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Friedman David J.,Kozlitina Julia,Genovese Giulio,Jog Prachi,Pollak Martin R.

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference29 articles.

1. U.S. Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2009

2. Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans

3. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

4. Apolipoprotein L, a New Human High Density Lipoprotein Apolipoprotein Expressed by the Pancreas

5. Apolipoprotein L1, a Novel Bcl-2 Homology Domain 3-only Lipid-binding Protein, Induces Autophagic Cell Death

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. APOL1 Nephropathy Risk Variants Through the Life Course: A Review;American Journal of Kidney Diseases;2024-07

2. APOL1 Kidney Risk Variants and Long-Term Kidney Function in Healthy Middle-Aged Black Individuals: The Atherosclerosis Risk in Communities (ARIC) Study;Kidney Medicine;2024-06

3. Novel Therapies in APOL1-Mediated Kidney Disease: From Molecular Pathways to Therapeutic Options;Kidney International Reports;2023-11

4. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease;Journal of the American Society of Nephrology;2023-10-06

5. Bioenergetics: the evolutionary basis of progressive kidney disease;Physiological Reviews;2023-10-01